Physician profile
Jana Bourn
NPI 1821204124
$669.92
in general payments reported to CMS, 2019-2025
18 companies · $25.36 in 2025
The $25.36 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $161 · 2021: $121 · 2022: $149 · 2023: $84.05 · 2025: $25.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $137.93 | 2019-2022 | |
| Abbvie INC. | $66.19 | 2021-2023 | Vraylar |
| Novartis Pharmaceuticals Corporation | $56.53 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.75 | 2022-2025 | |
| Allergan, INC. | $53.46 | 2019-2020 | |
| Amarin Pharma, INC. | $45.09 | 2019-2022 | |
| Pfizer INC. | $40.48 | 2021-2022 | |
| Corium, LLC | $33.58 | 2023 | Azstarys |
| Dexcom, INC. | $31.39 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.28 | 2020-2021 | |
| Sanofi Pasteur INC. | $23.00 | 2020 | |
| Amgen INC. | $16.78 | 2019 | |
| Esperion Therapeutics, INC. | $16.57 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.00 | 2021 | |
| Lilly USA, LLC | $14.68 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.56 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.27 | 2021 | |
| Mylan Specialty L.P. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jana Bourn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.